NADA Number: 141-038 | |
| Proprietary Name |
Adequan® Canine |
|---|---|
| Sponsor |
Luitpold Pharmaceuticals, Inc. |
| Ingredients |
Polysulfated Glycosaminoglycan |
| Species |
Dog, no use class stated or implied |
| Routes of Administration |
Intramuscular |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
| Exclusivity |
Granted for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints. |
|
Dosage Amount, Indications & Limitations |
522.1850 Polysulfated gylcosaminoglycan. Specifications: Each 1 milliliter ampule of sterile aqueous solution contains 250 milligrams of polysulfated glycosaminoglycan; each 5 milliliter ampule of vial contains 500 milligrams. Conditions of use: Dogs Amount: 2 milligrams per pound of body weight by intramuscular injection. Administer intramuscularly twice weekly for up to 4 weeks (maximum of 8 injections). Indications: For control of signs associated with noninfectious degenerative and/or traumatic arthritis of canine synovial joints. Limitations: Do not exceed recommended dose or regimen. Do not mix with other drugs or solvents. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |